haloperidol has been researched along with orphenadrine in 26 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 16 (61.54) | 18.7374 |
1990's | 2 (7.69) | 18.2507 |
2000's | 3 (11.54) | 29.6817 |
2010's | 5 (19.23) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Sen, S; Sinha, N | 1 |
Freiwald, S; Jiang, Y; Jones, JP; Kaspera, R; Katayama, J; Lee, CA; Smith, E; Totah, RA; Walker, GS | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Millar, WM | 1 |
Coppola, RJ; Rolek, DF | 1 |
Hemsley, DR; Philips, HC | 1 |
Bambrick, M; Wilson, D | 1 |
Henderson, RA; Henry, JA; Lane, S | 1 |
Altamura, AC; De Novellis, F; Mauri, MC; Percudani, M; Vampini, V | 1 |
Altamura, AC; Buccio, M; Colacurcio, F; Colombo, G; Terzi, A | 1 |
Peachey, C; Quinn, PT | 1 |
Malcolm, MT; Wells, PG | 1 |
Garattini, S; Morselli, PL; Rizzo, M; Zaccala, M | 1 |
Schipper, JA | 1 |
Collins, AJ; Horlington, M | 1 |
Ekdawi, MY; Fowke, R | 1 |
BEGHI, Q | 1 |
AMDISEN, A; JENSEN, K | 1 |
ROTH, M | 1 |
PERRIN, J; SCHNEIDER, J; SIFFERMANN, A; THOMALSKE, G | 1 |
FROGEL, M | 1 |
Cotroneo, A; De Fazio, P; De Fazio, S; De Sarro, G; Gallelli, L; Gareri, P; Lacava, R | 1 |
1 review(s) available for haloperidol and orphenadrine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for haloperidol and orphenadrine
Article | Year |
---|---|
Controlled trial of the treatment of 36 stutterers.
Topics: Adolescent; Adult; Clinical Trials as Topic; Female; Haloperidol; Humans; Intelligence Tests; Male; Middle Aged; Orphenadrine; Speech Therapy; Stuttering; Tic Disorders; Time Factors; Tourette Syndrome | 1971 |
[Depot-neuroleptics in the treatment of schizophrenia].
Topics: Adult; Chlorpromazine; Delayed-Action Preparations; Female; Fluphenazine; Haloperidol; Humans; Middle Aged; Orphenadrine; Perphenazine; Schizophrenia; Thioridazine | 1971 |
23 other study(ies) available for haloperidol and orphenadrine
Article | Year |
---|---|
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity.
Topics: Amiodarone; Astemizole; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Danazol; Drug Discovery; Drug Interactions; Enzyme Inhibitors; Humans; Hydroxylation; In Vitro Techniques; Methylation; Microsomes, Liver; Models, Biological; Molecular Structure; Substrate Specificity; Tandem Mass Spectrometry; Terfenadine | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Deaths after overdoses of orphenadrine.
Topics: Cause of Death; Drug Interactions; Drug Overdose; Haloperidol; Humans; Orphenadrine; Phenothiazines | 1977 |
A neuropharmacologic approach to self-mutilating behavior.
Topics: Animals; Cholinesterase Inhibitors; Depression, Chemical; Dopamine; Haloperidol; Humans; Male; Neostigmine; Orphenadrine; Rats; Receptors, Drug; Self Mutilation | 1975 |
Models of mania: An individual case study.
Topics: Adult; Bipolar Disorder; Electric Conductivity; Haloperidol; Heart Rate; Humans; Light; Lithium; Male; Models, Psychological; Orphenadrine; Plethysmography; Psychiatric Status Rating Scales; Reaction Time; Skin; Sweat Glands | 1975 |
Recurrent neuroleptic malignant syndrome in a man with mild mental handicap.
Topics: Adult; Antipsychotic Agents; Carbamazepine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Haloperidol; Humans; Intellectual Disability; Male; Neuroleptic Malignant Syndrome; Neurologic Examination; Orphenadrine; Recurrence; Sulpiride | 1992 |
Life-threatening ventricular arrhythmia (torsades de pointes) after haloperidol overdose.
Topics: Drug Overdose; Electrocardiography; Female; Haloperidol; Humans; Middle Aged; Orphenadrine; Torsades de Pointes; Ventricular Function | 1991 |
Residual neuroleptic-induced parkinsonian symptoms in schizophrenia. A naturalistic study with orphenadrine.
Topics: Adult; Aged; Female; Haloperidol; Humans; Male; Middle Aged; Orphenadrine; Parkinson Disease, Secondary; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1989 |
Orphenadrine plasma levels and amelioration of extrapyramidal side effects in schizophrenic patients treated with haloperidol.
Topics: Adolescent; Adult; Basal Ganglia Diseases; Female; Haloperidol; Humans; Male; Middle Aged; Orphenadrine; Schizophrenia | 1986 |
Stuttering. An investigation of haloperidol.
Topics: Adolescent; Adult; Anxiety; Haloperidol; Humans; Orphenadrine; Stuttering; Trifluoperazine | 1973 |
Haloperidol-desipramine interaction in mice, rats and man.
Topics: Animals; Basal Ganglia Diseases; Benperidol; Butyrophenones; Chronic Disease; Desipramine; Drug Antagonism; Female; Haloperidol; Humans; Kinetics; Male; Mice; Middle Aged; Motor Activity; Muscles; Orphenadrine; Psychotic Disorders; Rats; Tremor | 1970 |
A sequential screning test based on the running component of audiogenic seizures in mice, including reference compound PD50 values.
Topics: Acetazolamide; Animals; Anticonvulsants; Atropine; Chloral Hydrate; Chlordiazepoxide; Ethosuximide; Haloperidol; Hydroxybutyrates; Hypnotics and Sedatives; Meprobamate; Methods; Mice; Motor Activity; Orphenadrine; Phenobarbital; Phenytoin; Primidone; Sound | 1969 |
A controlled trial of anti-Parkinson drugs in drug-induced Parkinsonism.
Topics: Adolescent; Adult; Chlorpromazine; Haloperidol; Humans; Middle Aged; Orphenadrine; Parasympatholytics; Parkinson Disease; Parkinson Disease, Secondary; Perphenazine; Schizophrenia; Tranquilizing Agents; Trifluoperazine | 1966 |
[PSYCHIATRIC USE OF SOME PSYCHOPHARMACOLOGICAL DRUGS IN PREGNANCY].
Topics: Chlordiazepoxide; Chlorpromazine; Fetus; Haloperidol; Imipramine; Isocarboxazid; Meprobamate; Nialamide; Orphenadrine; Perphenazine; Pharmacology; Pregnancy; Prochlorperazine; Promazine; Psychopharmacology; Reserpine; Thalidomide; Thioridazine | 1963 |
TREATMENT OF DRUG-INDUCED PARKINSONISM: A COMPARISON BETWEEN UK-738, ORPHENADRINE, AND A PLACEBO IN A DOUBLE BLIND STUDY.
Topics: Clopenthixol; Double-Blind Method; Drug Therapy; Extrapyramidal Tracts; Haloperidol; Humans; Orphenadrine; Parasympatholytics; Parkinsonian Disorders; Perphenazine; Placebos; Tranquilizing Agents | 1964 |
DEPRESSIVE AND MANIC PSYCHOSES AND ALLIED DISORDERS.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Barbiturates; Bipolar Disorder; Depression; Electroconvulsive Therapy; Geriatrics; Haloperidol; Humans; Imipramine; Lithium; Mental Disorders; Middle Aged; Orphenadrine; Psychotherapy; Psychotic Disorders | 1964 |
[MODIFICATIONS OF THE EEG DUE TO PSYCHOPHARMACOLOGICAL TREATMENT. LONG-TERM STUDIES ON MENTAL PATIENTS].
Topics: Bemegride; Chlormethiazole; Chlorpromazine; Electroencephalography; Haloperidol; Humans; Hypnotics and Sedatives; Imipramine; Mental Disorders; Mentally Ill Persons; Meprobamate; Methotrimeprazine; Orphenadrine; Phenothiazines; Prochlorperazine; Psychopharmacology; Sympathomimetics; Trimeprazine | 1963 |
[EFFECT OF DRUG THERAPY ON REHOSPITALIZATIONS AT THE BEL AIR CLINIC OF PATIENTS WITH CHRONIC PSYCHOSES EXCEPT MANIC-DEPRESSIVE PSYCHOSES].
Topics: Bipolar Disorder; Chlorpromazine; Chlorprothixene; Convulsive Therapy; Drug Therapy; Haloperidol; Hospitalization; Humans; Insulin; Methotrimeprazine; Orphenadrine; Phenothiazines; Prognosis; Promazine; Psychotic Disorders; Reserpine; Statistics as Topic; Tranquilizing Agents; Trifluperidol | 1964 |
Anticholinergic drug-induced delirium in an elderly Alzheimer's dementia patient.
Topics: Acute Disease; Aged, 80 and over; Alzheimer Disease; Amitriptyline; Antipsychotic Agents; Cholinergic Antagonists; Delirium; Depressive Disorder, Major; Drug Therapy, Combination; GABA Modulators; Haloperidol; Humans; Lorazepam; Male; Orphenadrine | 2007 |